BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17310992)

  • 1. Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.
    Wang ZH; Shen B; Yao HL; Jia YC; Ren J; Feng YJ; Wang YZ
    Oncogene; 2007 Aug; 26(35):5107-14. PubMed ID: 17310992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells].
    Wang ZH; Feng YJ; Su M; Yi XF
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):111-5. PubMed ID: 17442186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo.
    Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
    Zhang Y; Feng Y; Chen L; Zhu J
    Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-Conductance-Ca2-Activated K Channel IKCa1 Is Upregulated and Promotes Cell Proliferation in Cervical Cancer.
    Liu L; Zhan P; Nie D; Fan L; Lin H; Gao L; Mao X
    Med Sci Monit Basic Res; 2017 Mar; 23():45-57. PubMed ID: 28280257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of blockage of intermediate conductance Ca(2+)-activated K (+) channels on proliferation of hepatocellular carcinoma cells.
    Yang XW; Liu JW; Zhang RC; Yin Q; Shen WZ; Yi JL
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):86-89. PubMed ID: 23392713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant.
    Wulff H; Miller MJ; Hansel W; Grissmer S; Cahalan MD; Chandy KG
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8151-6. PubMed ID: 10884437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.
    Stoneking CJ; Shivakumar O; Thomas DN; Colledge WH; Mason MJ
    Am J Physiol Cell Physiol; 2013 May; 304(9):C858-72. PubMed ID: 23407879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of Ca2+-activated K+ channels (IKCa1) by mibefradil in B lymphocytes.
    Yoo HY; Zheng H; Nam JH; Nguyen YH; Kang TM; Earm YE; Kim SJ
    Pflugers Arch; 2008 Jun; 456(3):549-60. PubMed ID: 18188587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells.
    Mark Duffy S; Berger P; Cruse G; Yang W; Bolton SJ; Bradding P
    J Allergy Clin Immunol; 2004 Jul; 114(1):66-72. PubMed ID: 15241346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
    Köhler R; Wulff H; Eichler I; Kneifel M; Neumann D; Knorr A; Grgic I; Kämpfe D; Si H; Wibawa J; Real R; Borner K; Brakemeier S; Orzechowski HD; Reusch HP; Paul M; Chandy KG; Hoyer J
    Circulation; 2003 Sep; 108(9):1119-25. PubMed ID: 12939222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1.
    Wulff H; Gutman GA; Cahalan MD; Chandy KG
    J Biol Chem; 2001 Aug; 276(34):32040-5. PubMed ID: 11425865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.
    Tao R; Lau CP; Tse HF; Li GR
    Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1409-16. PubMed ID: 18815226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Inhibition by Oxaliplatin, a Platinum-Based Anti-Neoplastic Agent, of the Activity of Intermediate-Conductance Ca²⁺-Activated K⁺ Channels in Human Glioma Cells.
    Huang MH; Huang YM; Wu SN
    Cell Physiol Biochem; 2015; 37(4):1390-406. PubMed ID: 26488725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences.
    Ghanshani S; Wulff H; Miller MJ; Rohm H; Neben A; Gutman GA; Cahalan MD; Chandy KG
    J Biol Chem; 2000 Nov; 275(47):37137-49. PubMed ID: 10961988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional ion channels and cell proliferation in 3T3-L1 preadipocytes.
    Zhang XH; Zhang YY; Sun HY; Jin MW; Li GR
    J Cell Physiol; 2012 May; 227(5):1972-9. PubMed ID: 21732368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II upregulates K(Ca)3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts.
    Wang LP; Wang Y; Zhao LM; Li GR; Deng XL
    Biochem Pharmacol; 2013 May; 85(10):1486-94. PubMed ID: 23500546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation.
    Abdullaev IF; Rudkouskaya A; Mongin AA; Kuo YH
    PLoS One; 2010 Aug; 5(8):e12304. PubMed ID: 20808839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.